MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors
1 clinical trials · Condition
◉ Watch MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors
| Record | Firm | Date |
|---|---|---|
| Evaluation of XYA02 in Patients With Advanced Solid Tumors (NCT07670312) | XYone Therapeutics, Inc | 2026-07-15 |
Track MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.